ST Tianmu Medicine: Revocation of other risk warnings and name change to Tianmu Pharmaceutical Industry.

ST Muyao Pharmaceuticals announced that the company's stock will be suspended for one day on May 19, 2025, and resume trading on May 20, 2025, with the removal of other risk warnings. After the removal of the risk warnings, the company's stock will be transferred from the risk warning board trading, and the daily price limit of the company's stock will be changed from 5% to 10%. The company's stock abbreviation will be changed from "ST Muyao" to "Tianmuyao Pharmaceuticals".